PLx Pharma Winddown Corp.: 10-Q filed 2019-11-08
What PLx Pharma Winddown Corp. reported in its quarterly report filed 2019-11-08 (fiscal Q3 2019): 37 published measures, 105 facts as tagged in accession 0001437749-19-022041.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-11-08
- Fiscal period
- fiscal Q3 2019
- Accession
- 0001437749-19-022041 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All PLx Pharma Winddown Corp. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 22,986,740 | USD | |
| At 2018-12-31 | 18,388,376 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 19,533,982 | USD | |
| At 2018-12-31 | 11,944,083 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -10,208,820 | USD | |
| At 2019-06-30 | -13,341,068 | USD | |
| At 2019-03-31 | -4,453,944 | USD | |
| At 2018-12-31 | 6,444,293 | USD | |
| At 2018-09-30 | 3,399,143 | USD | |
| At 2018-06-30 | 6,554,180 | USD | |
| At 2018-03-31 | 9,898,989 | USD | |
| At 2017-12-31 | 4,616,392 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 18,509,487 | USD | |
| At 2018-12-31 | 14,250,267 | USD | |
| At 2018-09-30 | 16,537,259 | USD | |
| At 2017-12-31 | 24,404,368 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,703,722 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -18,502,325 | USD | 273 |
| 2019-04-01 to 2019-06-30 | -9,347,296 | USD | 91 |
| 2019-01-01 to 2019-03-31 | -10,858,751 | USD | 90 |
| 2018-07-01 to 2018-09-30 | -3,425,073 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -2,049,885 | USD | 273 |
| 2018-04-01 to 2018-06-30 | -3,603,404 | USD | 91 |
| 2018-01-01 to 2018-03-31 | 4,978,592 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -9,022,626 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -7,212,239 | USD | 273 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 145,661 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 654,870 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 41,106 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 541,571 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 216,530 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 465,446 | USD | 273 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 13,416,065 | USD | 273 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -134,219 | USD | 273 |
| 2018-01-01 to 2018-09-30 | -654,870 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | -84,938,093 | USD | |
| At 2018-12-31 | -66,435,768 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 8,921,345 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 8,860,168 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 8,735,790 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 8,730,303 | shares | 273 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 8,936,255 | shares | 92 |
| 2019-01-01 to 2019-09-30 | 8,860,168 | shares | 273 |
| 2018-07-01 to 2018-09-30 | 8,735,790 | shares | 92 |
| 2018-01-01 to 2018-09-30 | 8,730,303 | shares | 273 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 0.09 | USD/shares | 92 |
| 2019-01-01 to 2019-09-30 | -3.6 | USD/shares | 273 |
| 2018-07-01 to 2018-09-30 | -0.39 | USD/shares | 92 |
| 2018-01-01 to 2018-09-30 | -0.23 | USD/shares | 273 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 0.09 | USD/shares | 92 |
| 2019-01-01 to 2019-09-30 | -3.6 | USD/shares | 273 |
| 2018-07-01 to 2018-09-30 | -0.39 | USD/shares | 92 |
| 2018-01-01 to 2018-09-30 | -0.23 | USD/shares | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 1,392,206 | USD | |
| At 2018-12-31 | 1,394,230 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 603,314 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 765,136 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | -3,676,237 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -10,444,720 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -2,802,773 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -8,437,725 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 18,759,850 | USD | |
| At 2018-12-31 | 14,865,410 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 6,173,884 | USD | |
| At 2018-12-31 | 4,732,660 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 2,061,022 | USD | |
| At 2018-12-31 | 2,061,022 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 3,717,343 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 10,986,291 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 3,019,303 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 8,903,171 | USD | 273 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 0 | USD | |
| At 2018-12-31 | 0 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,214,029 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 3,805,617 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 1,219,144 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 3,032,426 | USD | 273 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 9,122,990 | shares | |
| At 2018-12-31 | 8,743,950 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 699,996 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 763,630 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 488,599 | USD | |
| At 2018-12-31 | 84,281 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-09-30 | 250,363 | USD | |
| At 2018-12-31 | 421,933 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 1,703,722 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -18,502,325 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -3,425,073 | USD | 92 |
| 2018-01-01 to 2018-09-30 | -2,049,885 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 837,078 | USD | 92 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 2,503,314 | USD | 92 |
| 2019-01-01 to 2019-09-30 | 7,180,674 | USD | 273 |
| 2018-07-01 to 2018-09-30 | 1,800,159 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 5,870,745 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 126,692 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 145,218 | USD | 273 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-07-01 to 2019-09-30 | 5,379,959 | USD | 92 |
| 2019-01-01 to 2019-09-30 | -8,057,605 | USD | 273 |
| 2018-07-01 to 2018-09-30 | -622,300 | USD | 92 |
| 2018-01-01 to 2018-09-30 | 6,387,840 | USD | 273 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | 486,902 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 497,136 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-09-30 | -18,234 | USD | 273 |
| 2018-01-01 to 2018-09-30 | 22,107 | USD | 273 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-01-01 to 2018-09-30 | 524,245 | USD | 273 |
Inspect the source
- Entity
- PLx Pharma Winddown Corp. / CIK 0001497504
- Captured
- SEC response SHA-256
d5fa1894253c4a7ca3d44f3b07f2263d07de14ac7e8983994cead4448c203364
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001497504.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))